Bicycle Therapeutics
Jennifer Perry, PharmD, currently serves as Chief Strategy Officer and Head of Commercial at Bicycle Therapeutics since August 2022, following significant leadership roles in the biopharmaceutical industry. Previously, Jennifer held positions such as Senior Vice President and Vice President in Commercial and Global Scientific Engagement at Bicycle Therapeutics, and Vice President of Hematology Oncology Sales at TG Therapeutics, Inc. Prior experience includes Vice President of US Oncology Sales at GlaxoSmithKline Pharma and TESARO, along with leadership roles in medical affairs and strategic communications at Vaniam Group LLC and Pharmacyclics. Jennifer's academic background includes a PharmD from the University of Illinois Chicago and further studies at Loyola University Chicago.
This person is not in any teams
This person is not in any offices
Bicycle Therapeutics
2 followers
Bicycle is pioneering a new class of therapies based on its bicyclic peptide platform.